Another pathway that is implicated in the pathogenesis and progression of CCA is the insulin-like growth factor 2 (IGF2) signaling axis: its role extends beyond tumor growth, influencing metastasis, immune evasion, and therapy resistance. Here, IGF2 is linked to cholangiocarcinoma.